Please confirm topic selection

Are you sure you want to trigger topic in your Anconeus AI algorithm?

Please confirm action

You are done for today with this topic.

Would you like to start learning session with this topic items scheduled for future?

Updated: Oct 22 2019


  • Snapshot
    • A 40-year-old man with a past medical history of headaches presents to his primary care physician for persistent headaches and changes in his face. He reports that he can no longer fit his caps, his jaw seems larger, and there is increased spacing between his teeth. He reports some numbness and tingling in his hands. His physician orders an IGF1 test, which screens for acromegaly. This test comes back positive and an oral glucose load confirms the diagnosis of acromegaly. He is started on octreotide while he awaits imaging evaluation of his brain.
  • Introduction
    • Drugs
      • octreotide
    • Mechanism of action
      • octreotide is a somatostatin analog
        • inhibits secretion of splanchnic vasodilatory hormones
          • growth hormone
          • gastrin
          • vasoactive intestinal peptide (VIP)
          • glucagon
          • secretin
          • serotonin
          • pancreatic polypeptide
    • Clinical use
      • acute variceal bleeds
      • acromegaly
      • VIPoma
      • carcinoid tumors
      • glucagonoma
      • other neuroendocrine tumors
    • Adverse effects
      • gastrointestinal upset
      • steatorrhea
      • inhibits cholecystokinin, which increases the risk of cholelithiasis and cholecystitis
      • bradycardia
1 of 0
1 of 1
Private Note

Attach Treatment Poll
Treatment poll is required to gain more useful feedback from members.
Please enter Question Text
Please enter at least 2 unique options
Please enter at least 2 unique options
Please enter at least 2 unique options